Answers are grounded in this paper and cite their sources.
Dioscin exhibits anti-inflammatory, antioxidant, and neuroprotective activities. However, its regulatory effects on microglial ferroptosis and inflammatory responses, as well as the underlying mechanisms, remain unclear. This study aimed to investigate whether Dioscin attenuates oxygen–glucose deprivation/reoxygenation (OGD/R)-induced ferroptosis and inflammatory responses in microglia through a SIRT1-dependent mechanism involving the NADPH-associated FSP1/CoQ defense system. Using OGD/R-treated BV2 microglial cells as an in vitro model, we found that Dioscin dose-dependently ameliorated the OGD/R-induced reduction in cell viability and attenuated iron accumulation, lipid peroxidation, and proinflammatory cytokine release. Mechanistically, Dioscin increased SIRT1 expression and deacetylase activity, reduced the NADP + /NADPH ratio, and elevated membrane-associated FSP1 levels and the CoQ10H 2 /CoQ10 ratio. It also upregulated GPX4 expression while downregulating ACSL4 expression. Both the SIRT1 inhibitor EX-527 and siRNA-mediated knockdown of FSP1 attenuated the beneficial effects of Dioscin on oxidative stress- and ferroptosis-related markers (SOD, GSH, MDA, and Fe 2+ ) and proinflammatory cytokine levels (IL-1β, TNF-α, and IL-6). Further experiments showed that SIRT1 knockdown significantly increased the NADP + /NADPH ratio while reducing membrane-associated FSP1 levels and the CoQ10H 2 /CoQ10 ratio. Supplementation with exogenous NADPH significantly restored the NADP + /NADPH ratio and partially recovered membrane-associated FSP1 levels and CoQ redox status, but failed to restore total FSP1 protein levels. Subcellular fractionation analysis further revealed that Dioscin predominantly increased FSP1 levels in the membrane fraction. Molecular docking and molecular dynamics simulations suggested a potentially stable interaction between Dioscin and SIRT1. Collectively, these findings demonstrate that Dioscin attenuates OGD/R-induced ferroptosis-related injury and inflammatory responses in BV2 microglial cells. Its protective effects are closely associated with SIRT1-related NADPH redox homeostasis and membrane-associated FSP1/CoQ antioxidant defense, accompanied by changes in GPX4 and ACSL4 expression. The present study provides in vitro experimental evidence to support further investigation into the potential protective effects of Dioscin against cerebral ischemia–reperfusion-related cellular injury.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: